Download PDF
Horm Metab Res
DOI: 10.1055/a-2238-2553
Original Article: Endocrine Research

Periostin Promotes the Proliferation, Differentiation and Mineralization of Osteoblasts from Ovariectomized Rats

Jun Yan
1   Department of Orthopaedic Surgery, Liaocheng People’s Hospital, Liaocheng City, China
,
Zidong Wang
1   Department of Orthopaedic Surgery, Liaocheng People’s Hospital, Liaocheng City, China
,
Li Xian
2   School of Clinical Medicine, Weifang Medical University, Weifang, China
,
Dawei Wang
1   Department of Orthopaedic Surgery, Liaocheng People’s Hospital, Liaocheng City, China
,
Yunzhen Chen
3   Department of Spine, Qilu Hospital of Shandong University, Jinan, China
,
Jie Bai
4   Department of Endocrinology, Liaocheng People’s Hospital, Liaocheng City, China
,
Hai-juan Liu
4   Department of Endocrinology, Liaocheng People’s Hospital, Liaocheng City, China
› Author Affiliations Funding Information Natural Science Foundation of Shandong Province — http://dx.doi.org/10.13039/501100007129; ZR202102280280
› Further Information
Also available at
    Permissions and Reprints

Abstract

Perimenopausal period causes a significant amount of bone loss, which results in primary osteoporosis (OP). The Periostin (Postn) may play important roles in the pathogenesis of OP after ovariectomized (OVX) rats. To identify the roles of Postn in the bone marrow mesenchymal stem cell derived osteoblasts (BMSC-OB) in OVX rats, we investigated the expression of Wnt/β-catenin signaling pathways in BMSC-OB and the effects of Postn on bone formation by development of BMSC-OB cultures. Twenty-four female Sprague–Dawley rats at 6 months were randomized into 3 groups: sham-operated (SHAM) group, OVX group and OVX+Postn group. The rats were killed after 3 months, and their bilateral femora and tibiae were collected for BMSC-OB culture, Micro-CT Analysis, Bone Histomorphometric Measurement, Transmission Electron Microscopy and Immunohistochemistry Staining. The dose/time-dependent effects of Postn on the proliferation, differentiation and mineralization of BMSC-OB and the expression of osteoblastic markers were measured in in vitro experiments. We found increased Postn increased bone mass, promoted bone formation of trabeculae, Wnt signaling and the osteogenic activity in osteoblasts in sublesional femur. Postn have the function to enhance cell proliferation, differentiation and mineralization at a proper concentration and incubation time. Interestingly, in BMSC-OB from OVX rats treated with the different dose of Postn, the osteoblastic markers expression and Wnt/β-catenin signaling pathways were significantly promoted. The direct effect of Postn may lead to inhibit excessive bone resorption and increase bone formation through the Wnt/β-catenin signaling pathways after OVX. Postn may play a very important role in the pathogenesis of OP after OVX.

Keywords

osteoporosis - periostin - osteoblast


Publication History

Received: 24 July 2023

Accepted after revision: 23 December 2023

Article published online:
02 February 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Black DM, Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med 2016; 374: 254-262
    CrossrefPubMedGoogle Scholar
  • 2 Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet 2011; 377: 1276-1287
    CrossrefPubMedGoogle Scholar
  • 3 Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet 2019; 393: 364-376
    CrossrefPubMedGoogle Scholar
  • 4 Merle B, Garnero P. The multiple facets of periostin in bone metabolism. Osteoporos Int 2012; 23: 1199-1212
    CrossrefPubMedGoogle Scholar
  • 5 Cobo T, Viloria CG, Solares L. et al. Role of periostin in adhesion and migration of bone remodeling cells. PLoS One 2016; 11: e0147837
    CrossrefPubMedGoogle Scholar
  • 6 Bonnet N, Standley KN, Bianchi EN. et al. The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity. J Biol Chem 2009; 284: 35939-35950
    CrossrefPubMedGoogle Scholar
  • 7 Bonnet N, Garnero P, Ferrari S. Periostin action in bone. Mol Cell Endocrinol 2016; 432: 75-82
    CrossrefPubMedGoogle Scholar
  • 8 Yan J, Liu HJ, Li H. et al. Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women. Osteoporos Int 2017; 28: 2335-2341
    CrossrefPubMedGoogle Scholar
  • 9 Merle B, Bouet G, Rousseau JC. et al. Periostin and transforming growth factor beta-induced protein (TGFbetaIp) are both expressed by osteoblasts and osteoclasts. Cell Biol Int 2014; 38: 398-404
    CrossrefPubMedGoogle Scholar
  • 10 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
    CrossrefPubMedGoogle Scholar
  • 11 Li C, Li X, Wang X. et al. Periostin mediates oestrogen-induced osteogenic differentiation of bone marrow stromal cells in ovariectomised rats. Biomed Res Int 2020; DOI: 10.1155/2020/9405909.
    CrossrefPubMedGoogle Scholar
  • 12 Litvin J, Selim AH, Montgomery MO. et al. Expression and function of periostin-isoforms in bone. J Cell Biochem 2004; 92: 1044-1061
    CrossrefPubMedGoogle Scholar
  • 13 Allen MR, Hock JM, Burr DB. Periosteum: biology, regulation, and response to osteoporosis therapies. Bone 2004; 35: 1003-1012
    CrossrefPubMedGoogle Scholar
  • 14 Pepe J, Bonnet N, Herrmann FR. et al. Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure. Osteoporos Int 2018; 29: 339-346
    CrossrefPubMedGoogle Scholar
  • 15 Duchamp de Lageneste O, Colnot C. Periostin in bone regeneration. Adv Exp Med Biol 2019; 1132: 49-61
    CrossrefPubMedGoogle Scholar
  • 16 Amjadi-Moheb F, Akhavan-Niaki H. Wnt signaling pathway in osteoporosis: epigenetic regulation, interaction with other signaling pathways, and therapeutic promises. J Cell Physiol 2019; 234: 14641-14650
    CrossrefPubMedGoogle Scholar
  • 17 Manolagas SC. Wnt signaling and osteoporosis. Maturitas 2014; 78: 233-237
    CrossrefPubMedGoogle Scholar
  • 18 Morra L, Moch H. Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Arch 2011; 459: 465-475
    CrossrefPubMedGoogle Scholar
  • 19 Tkatchenko TV, Moreno-Rodriguez RA, Conway SJ. et al. Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. Physiol Genomics 2009; 39: 160-168
    CrossrefPubMedGoogle Scholar
  • 20 Lv J, Sun X, Ma J. et al. Involvement of periostin-sclerostin-Wnt/beta-catenin signaling pathway in the prevention of neurectomy-induced bone loss by naringin. Biochem Biophys Res Commun 2015; 468: 587-593
    CrossrefPubMedGoogle Scholar
  • 21 Bonnet N, Biver E, Durosier C. et al. Additive genetic effects on circulating periostin contribute to the heritability of bone microstructure. J Clin Endocrinol Metab 2015; 100: E1014-E1021
    CrossrefPubMedGoogle Scholar
  • 22 Bonnet N, Conway SJ, Ferrari SL. Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. Proc Natl Acad Sci U S A 2012; 109: 15048-15053
    CrossrefPubMedGoogle Scholar
  • 23 Zhu D, Wang Z, Zhang G. et al. Periostin promotes nucleus pulposus cells apoptosis by activating the Wnt/beta-catenin signaling pathway. FASEB J 2022; 36: e22369
    CrossrefPubMedGoogle Scholar
  • 24 Gerbaix M, Vico L, Ferrari SL. et al. Periostin expression contributes to cortical bone loss during unloading. Bone 2015; 71: 94-100
    CrossrefPubMedGoogle Scholar
  • 25 Kudo A. Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell. Cell Mol Life Sci 2011; 68: 3201-3207
    CrossrefPubMedGoogle Scholar
  • 26 Garnero P. New developments in biological markers of bone metabolism in osteoporosis. Bone 2014; 66: 46-55
    CrossrefPubMedGoogle Scholar
  • 27 Mosher DF, Johansson MW, Gillis ME. et al. Periostin and TGF-beta-induced protein: Two peas in a pod?. Crit Rev Biochem Mol Biol 2015; 50: 427-439
    PubMedGoogle Scholar
  • 28 Galli C, Piergianni M, Piemontese M. et al. Periostin improves cell adhesion to implantable biomaterials and osteoblastic differentiation on implant titanium surfaces in a topography-dependent fashion. J Biomed Mater Res A 2014; 102: 3855-3861
    CrossrefPubMedGoogle Scholar
  • 29 Heo SC, Shin WC, Lee MJ. et al. Periostin accelerates bone healing mediated by human mesenchymal stem cell-embedded hydroxyapatite/tricalcium phosphate scaffold. PLoS One 2015; 10: e0116698
    CrossrefPubMedGoogle Scholar
  • 30 Oshima A, Tanabe H, Yan T. et al. A novel mechanism for the regulation of osteoblast differentiation: transcription of periostin, a member of the fasciclin I family, is regulated by the bHLH transcription factor, twist. J Cell Biochem 2002; 86: 792-804
    CrossrefPubMedGoogle Scholar
  • 31 Zhu S, Barbe MF, Liu C. et al. Periostin-like-factor in osteogenesis. J Cell Physiol 2009; 218: 584-592
    CrossrefPubMedGoogle Scholar
  • 32 Horiuchi K, Amizuka N, Takeshita S. et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999; 14: 1239-1249
    CrossrefPubMedGoogle Scholar
  • 33 Ma Z, Zhao X, Deng M. et al. Bone marrow mesenchymal stromal cell-derived periostin promotes B-ALL progression by modulating CCL2 in leukemia cells. Cell Rep 2019; 26: 1533-1543 e1534
    CrossrefPubMedGoogle Scholar
  • 34 Zhong WJ, Zhang WB, Ma JQ. et al. Periostin-like-factor-induced bone formation within orthopedic maxillary expansion. Orthod Craniofac Res 2011; 14: 198-205
    CrossrefPubMedGoogle Scholar
  • 35 Lotz J, Gaertner T, Hahn M. et al. Collagen type I metabolism after bone surgery. Arch Orthop Trauma Surg 1999; 119: 212-216
    CrossrefPubMedGoogle Scholar